Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone
marrow (BM) investigation of patients with cytopenia and suspected myelodysplastic …

Abstract Machine learning (ML) algorithms are increasingly being used to help implement
clinical decision support systems. In this new field, we define as “translational machine …

This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic
investigation and evaluation of cytopenias of uncertain origin and suspected …

Myelodysplastic neoplasms (MDS) encompass haematological malignancies, which are
characterised by dysplasia, ineffective haematopoiesis and the risk of progression towards …

The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the
convergence of cytological, cytogenetic, and molecular factors. Multiparametric flow …

Mechanical properties of cells are important features that are tightly regulated and are
dictated by various pathologies. Deformability cytometry allows for the characterization of the …

Background The presence of> 94% classical monocytes (MO1, CD14++/CD16‐) in
peripheral blood (PB) has an excellent performance for the diagnosis of chronic …

Myelodysplastic neoplasms (MDS) are characterized by clonal evolution starting from the
compartment of hematopoietic stem and progenitors cells (HSPCs), leading in some cases …

During the process of hematopoiesis, hematopoietic stem cells (HSCs) undergo hierarchical
differentiation and maturation to develop into mature effector cells through a tightly regulated …

Advances in myelodysplastic syndrome : Current Opinion in Oncology Advances in
myelodysplastic syndrome : Current Opinion in Oncology Log in or Register Subscribe to …